Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Revlimid 10mg capsules
0802040Y0BBABAB
|
Revlimid | Lenalidomide | Malignant Disease and Immunosuppression | 1 |
|
Ribociclib 200mg tablets
0801050CRAAAAAA
|
Ribociclib | Ribociclib | Malignant Disease and Immunosuppression | 1 |
|
Rituximab 100mg/10ml solution for infusion vials
0802030F0AAABAB
|
Rituximab | Rituximab | Malignant Disease and Immunosuppression | 1 |
|
Sandimmun 50mg/1ml concentrate for inf ampoules
0802020G0BBACAA
|
Sandimmun | Ciclosporin | Malignant Disease and Immunosuppression | 1 |
|
Suprefact 5.5mg/5.5ml solution for injection vials
0803042B0BBAAAA
|
Suprefact | Buserelin | Malignant Disease and Immunosuppression | 1 |
|
Tacrolimus 4mg modified-release tablets
0802020T0AABEBE
|
Tacrolimus (Systemic) | Tacrolimus | Malignant Disease and Immunosuppression | 1 |
|
Tecfidera 120mg gastro-resistant capsules
0802040AKBBAAAA
|
Tecfidera | Dimethyl fumar | Malignant Disease and Immunosuppression | 1 |
|
Temoporfin 6mg/6ml solution for injection vials
0801050AKAAADAD
|
Temoporfin | Temoporfin | Malignant Disease and Immunosuppression | 1 |
|
Temozolomide 100mg capsules
0801050Y0AAAAAA
|
Temozolomide | Temozolomide | Malignant Disease and Immunosuppression | 1 |
|
Temozolomide 20mg capsules
0801050Y0AAADAD
|
Temozolomide | Temozolomide | Malignant Disease and Immunosuppression | 1 |
|
Temozolomide 5mg capsules
0801050Y0AAACAC
|
Temozolomide | Temozolomide | Malignant Disease and Immunosuppression | 1 |
|
Tretinoin 10mg capsules
0801050X0AAAAAA
|
Tretinoin (Systemic) | Tretinoin | Malignant Disease and Immunosuppression | 1 |
|
Abemaciclib 100mg tablets
0801050CLAAAAAA
|
Abemaciclib | Abemaciclib | Malignant Disease and Immunosuppression | No data available |
|
Abemaciclib 150mg tablets
0801050CLAAABAB
|
Abemaciclib | Abemaciclib | Malignant Disease and Immunosuppression | No data available |
|
Abemaciclib 50mg tablets
0801050CLAAACAC
|
Abemaciclib | Abemaciclib | Malignant Disease and Immunosuppression | No data available |
|
Abevmy 100mg/4ml concentrate for solution for infusion vials
0801050APBIAAAA
|
Abevmy | Bevacizumab | Malignant Disease and Immunosuppression | No data available |
|
Abevmy 400mg/16ml concentrate for inf vials
0801050APBIABAB
|
Abevmy | Bevacizumab | Malignant Disease and Immunosuppression | No data available |
|
Abiraterone 1g tablets
0803042T0AAACAC
|
Abiraterone | Abiraterone | Malignant Disease and Immunosuppression | No data available |
|
Abiraterone 250mg tablets
0803042T0AAAAAA
|
Abiraterone | Abiraterone | Malignant Disease and Immunosuppression | No data available |
|
Afatinib 20mg tablets
0801050BPAAACAC
|
Afatinib | Afatinib | Malignant Disease and Immunosuppression | No data available |
|
Afatinib 30mg tablets
0801050BPAAAAAA
|
Afatinib | Afatinib | Malignant Disease and Immunosuppression | No data available |
|
Afatinib 40mg tablets
0801050BPAAABAB
|
Afatinib | Afatinib | Malignant Disease and Immunosuppression | No data available |
|
Afatinib 50mg tablets
0801050BPAAADAD
|
Afatinib | Afatinib | Malignant Disease and Immunosuppression | No data available |
|
Afinitor 2.5mg tablets
0801050AXBBACAC
|
Afinitor | Everolimus | Malignant Disease and Immunosuppression | No data available |
|
Afinitor 5mg tablets
0801050AXBBAAAA
|
Afinitor | Everolimus | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.